SCHEMBL7947843

SCHEMBL7947843

CC/C(=C\C(=O)O)c1ccccc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.47
KMT2A Q03164 3/20 0.46
ERCC5 P28715 1/20 0.46
FEN1 P39748 1/20 0.46
TSHR P16473 2/20 0.44
MAPK1 P28482 2/20 0.44
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
GPR52 Q9Y2T5 1/20 0.43
FFAR1 O14842 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
GAA P10253 2/20 0.41
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29119395 0.84 ALDH1A1 (0.52) HPGDKMT2ATSHRALDH1A1KDM4E
SCHEMBL29119429 0.84 KDM4E (0.50) HPGDKMT2ATSHRALDH1A1KDM4E
SCHEMBL9510857 0.81 HPGD (0.47) HPGDKMT2AALDH1A1KDM4ECYP1A2
SCHEMBL18508975 0.79 HPGD (0.41) HPGDKMT2AERCC5FEN1TSHR
SCHEMBL7955212 0.78 ALDH1A1 (0.38) TSHRALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL2303277 0.77 PDPK1 (0.51) HPGDKMT2AKDM4ESMN1; SMN2MEN1
SCHEMBL2303273 0.77 PDPK1 (0.51) HPGDKMT2AKDM4ESMN1; SMN2MEN1
SCHEMBL6515252 0.77 PDPK1 (0.51) HPGDKMT2AKDM4ESMN1; SMN2MEN1
SCHEMBL18084151 0.77 HPGD (0.40) HPGDKMT2AERCC5FEN1TSHR
SCHEMBL8949240 0.76 TSHR (0.50) HPGDKMT2AERCC5FEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211197-B1 CARBOXYLIC ACID OR TETRAZOLE DERIVATES; ANALGESICS, ANTIPYRETICS, AND ANTIINFLAMMATORY AGENTS; SIDE EFFECT REDUCTION MERCK FROSST CANADA & CO. (CA) 2001-04-03 US disclosed